Related references
Note: Only part of the references are listed.Hepatitis B Virus Drug Resistance in HIV-1-Infected Patients Taking Lamivudine-Containing Antiretroviral Therapy
Pawinee Wongprasit et al.
AIDS PATIENT CARE AND STDS (2010)
Efficacy and Safety of 1-Month Postpartum Zidovudine-Didanosine to Prevent HIV-Resistance Mutations after Intrapartum Single-Dose Nevirapine
Marc Lallemant et al.
CLINICAL INFECTIOUS DISEASES (2010)
Prevention in Neglected Subpopulations: Prevention of Mother-to-Child Transmission of HIV Infection
Lynne M. Mofenson
CLINICAL INFECTIOUS DISEASES (2010)
Association between Detection of HIV-1 DNA Resistance Mutations by a Sensitive Assay at Initiation of Antiretroviral Therapy and Virologic Failure
Gonzague Jourdain et al.
CLINICAL INFECTIOUS DISEASES (2010)
Detection of HIV-1 Drug Resistance in Women Following Administration of a Single Dose of Nevirapine: Comparison of Plasma RNA to Cellular DNA by Consensus Sequencing and by Oligonucleotide Ligation Assay
Thor A. Wagner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Antiretroviral Therapies in Women after Single-Dose Nevirapine Exposure
S. Lockman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effectiveness of Non-nucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Women Previously Exposed to a Single Intrapartum Dose of Nevirapine: A Multi-country, Prospective Cohort Study
Jeffrey S. A. Stringer et al.
PLOS MEDICINE (2010)
Intrapartum Tenofovir and Emtricitabine Reduces Low-Concentration Drug Resistance Selected by Single-Dose Nevirapine for Perinatal HIV Prevention
Benjamin H. Chi et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Early Postpartum Pharmacokinetics of Lopinavir Initiated Intrapartum in Thai Women
Tim R. Cressey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Persistent Minority K103N Mutations among Women Exposed to Single-Dose Nevirapine and Virologic Response to Nonnucleoside Reverse-Transcriptase Inhibitor-Based Therapy
Ashraf Coovadia et al.
CLINICAL INFECTIOUS DISEASES (2009)
Efficacy of Short-Course AZT Plus 3TC to Reduce Nevirapine Resistance in the Prevention of Mother-to-Child HIV Transmission: A Randomized Clinical Trial
James A. McIntyre et al.
PLOS MEDICINE (2009)
Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006
Patrick A. Coffie et al.
CLINICAL INFECTIOUS DISEASES (2008)
Antiretroviral drug resistance testing in adult HIV-1 infection:: 2008 recommendations of an International AIDS Society-USA panel
Martin S. Hirsch et al.
CLINICAL INFECTIOUS DISEASES (2008)
Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants
Ingrid A. Beck et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial
Benjamin H. Chi et al.
LANCET (2007)
Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine
Benjamin H. Chi et al.
AIDS (2007)
Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected children
Marie-Laure Chaix et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Response to antiretroviral therapy after a single, peripartum dose of nevirapine
Shahin Lockman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission
S Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission
Shayne Loubser et al.
AIDS (2006)
Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy
JM Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire
ML Chaix et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP
SH Eshleman et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012)
SH Eshleman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma
GM Ellis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy
G Jourdain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand
M Lallemant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors
IA Beek et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
An overview of a hepatitis B serology screening check-up program among Thai workers
V Wiwanitkit
VIRAL IMMUNOLOGY (2002)
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
SH Eshleman et al.
AIDS (2001)
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1
L Mandelbrot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
